Global Health Ltd

Q3 FY25 Earnings Call Analysis

Healthcare Services

Full Stock Analysis
revenue: Category 3margin: Category 3orderbook: No informationfundraise: No informationcapex: Yes
💰

fundraise

Any current/future new fundraising through debt or equity?

- There is no explicit mention of any current or future fundraising through debt or equity in the provided transcript. - The company highlights disciplined capital allocation and maintains a healthy balance sheet. - Expansion projects like Guwahati, Mumbai, South Delhi, Pitampura, and others are ongoing, with construction timelines around 3 to 4 years, but no specific mention of fundraising plans related to these. - The company seems focused on steady growth and operational ramp-up without indicating immediate need for additional funds via debt or equity. - No direct guidance or announcements regarding fundraising were made during the Q2 FY26 earnings call.
🏗️

capex

Any current/future capex/capital investment/strategic investment?

- Guwahati Project: Completed acquisition of 3.5-acre land (~INR 600 million); Bhoomi Pujan done on October 31, 2025; construction commencement underway; expected 3-4 years to complete. - Mumbai, Oshiwara Project: Received approval for increased FSI, expanding bed capacity from 500 to 750; Board approved new project cost of INR 15,300 million including land, construction, medical equipment, and INR 850 million for staff residential apartments; construction to start soon. - South Delhi & Pitampura Projects: Digging started in South Delhi; Pitampura plans submitted for approval and construction to commence post-approval; timeline also expected around 3-4 years. - Ranchi Expansion: Commissioned 110 new beds; plans to add Oncology services and optimize specialty mix. - Noida Hospital: Operational since September 2025; ongoing ramp-up and investments expected. - Overall, multiple projects underway with 3-4 year build-out timelines and continued capital allocation focused on growth and strategic expansion.
📊

revenue

Future growth expectations in sales/revenue/volumes?

- Developing hospitals (Lucknow, Patna, Noida) continue strong double-digit growth; revenue up ~30% YoY including Noida. - Lucknow hospital showing 30% inpatient volume growth, occupancy ~67%, driven by added clinical talent and specialties. - Ranchi facility expanding with new specialties and Oncology services planned; volumes growing ~15% YoY. - Noida hospital operational since Sept 2025, early contribution noted; insurance empanelments expected soon to accelerate growth. - Additional beds opened in Patna and Lucknow; more bed additions planned, supporting volume growth without necessarily requiring new hospitals. - New projects in Guwahati, Mumbai (Oshiwara), South Delhi, and Pitampura progressing; expected commissioning ~3-4 years out. - Growth drivers include bed expansion, specialist additions, and procedural complexity (e.g., robotic surgeries). - International patient revenue up 49% YoY, indicating growth potential from overseas market.
📈

margin

Future growth expectations in earnings/operating earnings/profits/EPS?

- Management is optimistic about future growth, expecting steady ramp-up and improved performance in developing hospitals like Noida, Lucknow, Patna, and Ranchi over the next 12-18 months. - New facilities (e.g., Ranchi expansion with 110 beds, Lucknow additions) are expected to gradually improve EBITDA margins as they stabilize. - Mature hospitals showing modest EBITDA growth (~2% YoY); expects further margin improvement as additional manpower cost normalizes. - Noida operational losses (~INR 20 crore EBITDA loss currently) expected to reduce as the hospital scales up, but no specific timeline or numbers given. - ARPOB (average revenue per occupied bed) expected to stay strong with specialty mix optimization and growing complex care, especially in developing hospitals. - New projects (Mumbai, Guwahati, South Delhi, Pitampura) are 3-4 years away, anticipated to contribute to growth beyond FY27. - Conservative pricing approach maintained, with selective modest price increases; Patna price unchanged due to market strategy. - Overall outlook reflects confidence in sustained volume growth, margin improvement, and disciplined capital allocation.
📋

orderbook

Current/ Expected Orderbook/ Pending Orders?

The provided transcript does not contain specific details about the current or expected order book or pending orders for Global Health Limited – Medanta. The discussion primarily focuses on hospital operations, bed expansions, revenue growth, EBITDA margins, insurance empanelments, and ongoing construction projects. Key points relevant to projects include: - Ongoing projects at South Delhi and Pitampura have commenced or are awaiting approvals; construction to follow. - Mumbai project now approved for 750 beds with construction approvals in progress. - Guwahati project land possession and Bhoomi Pujan completed; design work underway. - Typical hospital construction timeline is 3 to 4 years. - No explicit financial order book or specific pending order figures disclosed. For precise order book or pending orders data, please refer to detailed financial disclosures or investor communications beyond this transcript.